Adagio Medical Holdings (ADGM) Gross Margin (2023 - 2024)
Adagio Medical Holdings (ADGM) reported Gross Margin of 213.64% for Q3 2024, up 30344.0% year-over-year from N/an in Q4 2023, and down 26.78% quarter-over-quarter from 168.5% in Q2 2024.
Adagio Medical Holdings (ADGM) Gross Margin (2023 - 2024) Analysis & Trends
Adagio Medical Holdings (ADGM) has 2 years of Gross Margin data on file, last reported at 213.64% in Q3 2024.
- Gross Margin for Q3 2024 came in at 213.64%, up 30344.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 472.73% (changed N/A YoY), and the FY2024 annual result was 620.07%, down 28474.0% from the prior year.
- Gross Margin retreated to 213.64% in Q3 2024 per ADGM's latest filing, from 168.5% in the prior quarter.
- Over five years, Gross Margin peaked at 168.5% in Q2 2024 and troughed at 1984.62% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 43.89% |
| 10 | Adagio Medical Holdings | 15.88 Mn | 2.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -213.64% |
| Jun 30, 2024 | -168.50% |
| Mar 31, 2024 | -1,984.62% |
| Dec 31, 2023 | -328.21% |
| Sep 30, 2023 | -517.07% |